BSE Live
Dec 24, 16:01Prev. Close
22.75
Open Price
21.62
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 24, 15:57Prev. Close
22.81
Open Price
21.67
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
21.67 (18751)
| Key Financial Ratios of Vivimed Labs (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 16.60 | 15.53 | 14.74 | 18.53 | 12.77 | |
| Diluted EPS (Rs.) | 16.60 | 15.53 | 14.74 | 18.53 | 12.77 | |
| Cash EPS (Rs.) | 21.87 | 19.69 | 19.23 | 22.68 | 15.25 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 117.89 | 98.13 | 84.35 | 88.31 | 66.00 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 118.89 | 99.19 | 85.42 | 89.69 | 66.00 | |
| Dividend / Share(Rs.) | 1.50 | 1.50 | 1.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 211.33 | 161.14 | 165.52 | 174.00 | 105.26 | |
| PBDIT/Share (Rs.) | 41.10 | 33.21 | 29.48 | 33.54 | 22.71 | |
| PBIT/Share (Rs.) | 36.69 | 29.64 | 26.17 | 30.10 | 20.49 | |
| PBT/Share (Rs.) | 22.20 | 19.46 | 20.49 | 24.61 | 17.89 | |
| Net Profit/Share (Rs.) | 16.60 | 15.53 | 14.74 | 18.53 | 12.77 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 19.45 | 20.60 | 17.80 | 19.27 | 21.57 | |
| PBIT Margin (%) | 17.36 | 18.39 | 15.81 | 17.29 | 19.46 | |
| PBT Margin (%) | 10.50 | 12.07 | 12.38 | 14.14 | 16.99 | |
| Net Profit Margin (%) | 7.85 | 9.63 | 8.90 | 10.64 | 12.13 | |
| Return on Networth / Equity (%) | 14.07 | 15.82 | 17.47 | 20.98 | 19.34 | |
| Return on Capital Employed (%) | 8.61 | 7.52 | 8.47 | 14.69 | 15.44 | |
| Return on Assets (%) | 5.18 | 4.77 | 5.91 | 8.84 | 11.63 | |
| Total Debt/Equity (X) | 1.26 | 1.87 | 1.38 | 0.77 | 0.31 | |
| Asset Turnover Ratio (%) | 65.99 | 49.54 | 66.39 | 83.02 | 95.90 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.34 | 1.28 | 1.82 | 1.51 | 2.17 | |
| Quick Ratio (X) | 0.86 | 0.83 | 1.22 | 0.87 | 1.46 | |
| Inventory Turnover Ratio (X) | 3.47 | 3.04 | 3.64 | 3.27 | 5.45 | |
| Dividend Payout Ratio (NP) (%) | 9.03 | 11.30 | 7.93 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 6.85 | 8.91 | 6.08 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 90.97 | 88.70 | 92.07 | 0.00 | 100.00 | |
| Cash Earnings Retention Ratio (%) | 93.15 | 91.09 | 93.92 | 0.00 | 100.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 286.91 | 205.34 | 178.82 | 170.22 | 175.75 | |
| EV/Net Operating Revenue (X) | 1.36 | 1.36 | 1.15 | 1.35 | 2.30 | |
| EV/EBITDA (X) | 7.00 | 6.58 | 6.45 | 6.99 | 10.66 | |
| MarketCap/Net Operating Revenue (X) | 0.68 | 0.26 | 0.54 | 0.98 | 2.11 | |
| Retention Ratios (%) | 90.96 | 88.69 | 92.06 | 0.00 | 100.00 | |
| Price/BV (X) | 1.21 | 0.43 | 1.07 | 1.93 | 3.37 | |
| Price/Net Operating Revenue | 0.68 | 0.26 | 0.54 | 0.98 | 2.11 | |
| Earnings Yield | 0.12 | 0.37 | 0.16 | 0.11 | 0.06 |
14.11.2025
Vivimed Labs Consolidated September 2025 Net Sales at Rs 20.61 crore, down 16.79% Y-o-Y
14.11.2025
Vivimed Labs Standalone September 2025 Net Sales at Rs 18.66 crore, down 15.8% Y-o-Y
24.06.2025
Vivimed Labs Standalone March 2025 Net Sales at Rs 22.58 crore, down 37.95% Y-o-Y
03.06.2025
Vivimed Labs Consolidated March 2025 Net Sales at Rs 25.61 crore, down 33.67% Y-o-Y
14.11.2025
Vivimed Labs Consolidated September 2025 Net Sales at Rs 20.61 crore, down 16.79% Y-o-Y
14.11.2025
Vivimed Labs Standalone September 2025 Net Sales at Rs 18.66 crore, down 15.8% Y-o-Y
24.06.2025
Vivimed Labs Standalone March 2025 Net Sales at Rs 22.58 crore, down 37.95% Y-o-Y
03.06.2025
Vivimed Labs Consolidated March 2025 Net Sales at Rs 25.61 crore, down 33.67% Y-o-Y